HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Target, Wal-Mart Move Pseudoephedrine Behind The Counter

This article was originally published in The Tan Sheet

Executive Summary

Target Corporation is the first national retail chain to move all pseudoephedrine-containing products behind pharmacy counters, the firm announced April 18

You may also be interested in...

Retailers Put Pseudoephedrine Behind Counters, Lend Weight To Talent Bill

A wave of decisions from leading OTC drug retailers to place pseudoephedrine solids behind the counter could provide momentum for a federal pseudoephedrine BTC bill

Behind Which Counter? Pseudoephedrine Bill Slated For Judiciary Action

National debate over a meth-control strategy is now focused on a choice between pharmacy-counter sale of pseudoephedrine and a more flexible retail-counter option

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts